Home › NDC Lookup › RxCUI directory › RxCUI 1013930

12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet — RxCUI 1013930

RxNorm drug concept · Semantic clinical drug
RxCUI 1013930 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1013930
Official name12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascloNIDine HCl 0.1 MG 12HR Extended Release Oral Tablet
FDA products mapped11
Package NDCs mapped13
Reported Medicaid activity (SDUD)411,567 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clonidine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The clonidine patch is used to treat high blood pressure. Instead of swallowing a pill every day, you apply this patch to your skin once a week and it releases a steady, controlled...
  • What is this patch actually for, and how is it different from a blood pressure pill?
  • Apply it to a hairless area of intact skin — the upper outer arm or the chest are the recommended spots. Each time you put on a new patch, use a different area from the previous on...
  • Where do I put the patch, and does it matter where?
📖 Read our full Clonidine Transdermal Patch guide →

🕸️ Concept Web — How 12 HR clonidine hydrochloride 0.1 MG Extended Re... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet RxCUI 1013930

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Clonidine 2599
    • Clonidine hydrochloride 142432
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Kapvay 1013931
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clonidine Extended Release Oral Tablet 885794
    • Clonidine hydrochloride Extended Release Oral Tablet 2646561
    • Clonidine Oral Product 1153385
    • Clonidine Pill 1153386
    • Clonidine hydrochloride Oral Product 2660238
    • Clonidine hydrochloride Pill 2660623
    • Clonidine Extended Release Oral Tablet [Kapvay] 1013933
    • Clonidine hydrochloride Extended Release Oral Tablet [Kapvay] 2655696
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Clonidine hydrochloride 0.1 MG 884172
    • 12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet [Kapvay] 1013934
    • Clonidine hydrochloride 0.1 MG [Kapvay] 1013932

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clonidine hydrochloride 0.1 MG SCDC · 884172
  • Clonidine Extended Release Oral Tablet SCDF · 885794
  • Clonidine hydrochloride Extended Release Oral Tablet SCDFP · 2646561
  • Clonidine Oral Product SCDG · 1153385
  • Clonidine Pill SCDG · 1153386
  • Clonidine hydrochloride Oral Product SCDGP · 2660238
  • Clonidine hydrochloride Pill SCDGP · 2660623

Brand-Name Concepts

  • 12 HR clonidine hydrochloride 0.1 MG Extended Release Oral Tablet [Kapvay] SBD · 1013934
  • Clonidine hydrochloride 0.1 MG [Kapvay] SBDC · 1013932
  • Clonidine Extended Release Oral Tablet [Kapvay] SBDF · 1013933
  • Clonidine hydrochloride Extended Release Oral Tablet [Kapvay] SBDFP · 2655696
  • Kapvay Oral Product SBDG · 1169289
  • Kapvay Pill SBDG · 1169290
  • Kapvay BN · 1013931

📦 FDA Products & Package NDCs

11 products · 13 package NDCs
13 package NDCs map to RxCUI 1013930 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-4241-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-4241-06) Clonidine Hydrochloride Actavis Pharma, Inc. 2015-06-17
27241-0108-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-108-06) Clonidine hydrochloride Ajanta Pharma USA Inc. 2017-11-21
43547-0435-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-435-06) Clonidine Hydrochloride Solco Healthcare LLC 2018-02-15
50742-0247-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-247-05) Clonidine Ingenus Pharmaceuticals, LLC 2019-03-05
50742-0247-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-247-30) Clonidine Ingenus Pharmaceuticals, LLC 2019-03-05
50742-0247-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-247-60) Clonidine Ingenus Pharmaceuticals, LLC 2019-03-05
60687-0462-21 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-462-21) / 1 TABL... Clonidine hydrochloride American Health Packaging 2019-12-17
63629-1208-01 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1208-1) Clonidine Hydrochloride Bryant Ranch Prepack 2024-07-08
68001-0568-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-568-06) Clonidine hydrochloride BluePoint Laboratories 2023-08-24
68180-0606-07 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-606-07) Clonidine Hydrochloride Lupin Pharmaceuticals, Inc. 2018-02-07
70069-0044-01 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70069-044-01) Clonidine Hydrochloride Somerset Therapeutics, LLC 2025-03-04
71034-0001-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71034-001-60) Clonidine Hydrochloride Xiamen LP Pharmaceutical Co., Ltd. 2017-12-01
72162-1367-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-1367-6) Clonidine Hydrochloride Bryant Ranch Prepack 2024-07-16
Observed labelers: Ingenus Pharmaceuticals, LLC (3) · Bryant Ranch Prepack (2) · Actavis Pharma, Inc. (1) · Ajanta Pharma USA Inc. (1) · American Health Packaging (1) · BluePoint Laboratories (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.2436
Range $0.2436–$0.2436 · middle 50% $0.2436–$0.2436 · 7 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.